Product Spotlight: Hot Flash® - Safe, Natural HRT Alternative

Public confidence in hormone replacement therapy (HRT) suffered a major blow in July 2002, when the government halted a large clinical trial out of concern for the safety of participants. The study, conducted by the National Heart, Lung, and Blood Institute of the National Institues of Health, was ended three years early because researchers found a small but unacceptable increase in the rate of breast cancer among women taking the estrogen/progestin combination. The study, reported in the Journal of the American Medical Association (7/17/02), also showed an increase in heart attacks, strokes, and blood clots in the lungs and legs.